4//SEC Filing
Engelson Erik T. 4
Accession 0001209191-21-009037
CIK 0001652724other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 7:47 PM ET
Size
8.9 KB
Accession
0001209191-21-009037
Insider Transaction Report
Form 4
Engelson Erik T.
DirectorPresident and Chief Executive
Transactions
- Conversion
Common Stock
2021-02-09+23,282→ 23,282 total - Conversion
Series C Preferred Stock
2021-02-09−23,282→ 0 total→ Common Stock (23,282 underlying)
Holdings
- 191,705(indirect: See footnote)
Common Stock
- 46,400(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Each share of Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date.
- [F2]The shares are held by the Elisabeth North Keuchler Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
- [F3]The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Lucira Health, Inc.
CIK 0001652724
Entity typeother
Related Parties
1- filerCIK 0001839384
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 7:47 PM ET
- Size
- 8.9 KB